−215.12 M SEK
5.96 M SEK
35.26 M
About CINCLUS PHARMA HOLDING AB
Sector
Industry
CEO
Christer Ahlberg
Website
Headquarters
Stockholm
Founded
2017
ISIN
SE0020388577
FIGI
BBG01N9ZMWF0
Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CINPHA is 21.380 SEK — it has increased by 4.29% in the past 24 hours. Watch CINCLUS PHARMA HOLDING AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CINCLUS PHARMA HOLDING AB stocks are traded under the ticker CINPHA.
CINPHA stock has risen by 5.35% compared to the previous week, the month change is a 9.64% rise, over the last year CINCLUS PHARMA HOLDING AB has showed a −46.55% decrease.
We've gathered analysts' opinions on CINCLUS PHARMA HOLDING AB future price: according to them, CINPHA price has a max estimate of 80.00 SEK and a min estimate of 56.00 SEK. Watch CINPHA chart and read a more detailed CINCLUS PHARMA HOLDING AB stock forecast: see what analysts think of CINCLUS PHARMA HOLDING AB and suggest that you do with its stocks.
CINPHA reached its all-time high on Jun 20, 2024 with the price of 40.000 SEK, and its all-time low was 18.810 SEK and was reached on Dec 4, 2024. View more price dynamics on CINPHA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CINPHA stock is 5.58% volatile and has beta coefficient of 0.21. Track CINCLUS PHARMA HOLDING AB stock price on the chart and check out the list of the most volatile stocks — is CINCLUS PHARMA HOLDING AB there?
Yes, you can track CINCLUS PHARMA HOLDING AB financials in yearly and quarterly reports right on TradingView.
CINPHA net income for the last quarter is −36.55 M SEK, while the quarter before that showed −40.33 M SEK of net income which accounts for 9.38% change. Track more CINCLUS PHARMA HOLDING AB financial stats to get the full picture.
No, CINPHA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 13.00 employees. See our rating of the largest employees — is CINCLUS PHARMA HOLDING AB on this list?
Like other stocks, CINPHA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CINCLUS PHARMA HOLDING AB stock right from TradingView charts — choose your broker and connect to your account.